Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis

IMPORTANCE: Direct oral anticoagulant (DOAC)–associated intracranial hemorrhage (ICH) has high morbidity and mortality. The safety and outcome data of DOAC reversal agents in ICH are limited. OBJECTIVE: To evaluate the safety and outcomes of DOAC reversal agents among patients with ICH. DATA SOURCES...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Rahul, Singh, Amteshwar, Chaudhary, Rohit, Bashline, Michael, Houghton, Damon E., Rabinstein, Alejandro, Adamski, Jill, Arndt, Richard, Ou, Narith N., Rudis, Maria I., Brown, Caitlin S., Wieruszewski, Erin D., Wanek, Matthew, Brinkman, Nathan J., Linderbaum, Jane A., Sorenson, Melissa A., Atkinson, John L., Thompson, Kristine M., Aiyer, Aryan N., McBane, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636520/
https://www.ncbi.nlm.nih.gov/pubmed/36331504
http://dx.doi.org/10.1001/jamanetworkopen.2022.40145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636520/
https://www.ncbi.nlm.nih.gov/pubmed/36331504
http://dx.doi.org/10.1001/jamanetworkopen.2022.40145

Ejemplares similares